ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 320 out of 1107

$754K Total Retail Price of All Prescriptions

Rank: 185 out of 1107

574 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 574 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 574 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 6,363 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
PRAVASTATIN SODIUM 333 285 1 12
HYDROCODONE-ACETAMINOPHEN 322 158 S3 2 1
OMEPRAZOLE 297 217 3 4
LISINOPRIL 272 140 4 2
AMLODIPINE BESYLATE 257 206 5 6
SIMVASTATIN 248 202 6 5
LEVOTHYROXINE SODIUM 245 146 7 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 207 127 8 24
ATORVASTATIN CALCIUM 194 139 9 13
CRESTOR 167 92 10 23
CARVEDILOL 166 113 11 27
FLUOXETINE HCL 163 86 12 47
FUROSEMIDE 155 87 13 7
METFORMIN HCL 145 79 14 8
SPIRIVA 138 126 15 57
BYSTOLIC 134 122 16 138
CYMBALTA 120 61 17 50
CITALOPRAM HBR 108 31 18 17
METOPROLOL TARTRATE 108 70 18 10
METFORMIN HCL ER 101 48 20 58
NEXIUM 94 42 21 18
DIOVAN HCT 94 77 21 106
OXYCODONE HCL 93 0 S2 23 100
HYDROCHLOROTHIAZIDE 92 49 24 11
ZOLPIDEM TARTRATE 90 66 25 22
PANTOPRAZOLE SODIUM 90 47 25 30
WARFARIN SODIUM 81 77 27 15
LANTUS 80 50 28 49
GABAPENTIN 79 20 29 9
ATENOLOL 79 39 29 19
LOSARTAN-HYDROCHLOROTHIAZIDE 78 47 31 66
CELEBREX 78 67 31 85
OXYCODONE HCL-ACETAMINOPHEN 75 30 S2 33 93
DIOVAN 75 39 33 51
PLAVIX 75 41 33 39
OXYCODONE-ACETAMINOPHEN 74 26 S2 36 104
CLONIDINE HCL 73 35 37 53
GLYBURIDE-METFORMIN HCL 73 67 R 37 165
SPIRONOLACTONE 72 43 39 72
OPANA ER 68 0 S2 40 253
TAMSULOSIN HCL 67 40 41 30
EXFORGE 63 61 42 221
INSULIN SYRINGE 62 43 43 78
DILTIAZEM ER 59 49 44 139
TRIAMTERENE-HCTZ 57 40 45 62
CLOPIDOGREL 57 32 45 28
METOPROLOL SUCCINATE 55 55 47 16
BUPROPION HCL SR 55 32 47 190
POTASSIUM CHLORIDE 54 41 49 14
JANUMET 52 29 50 197
LIPITOR 50 32 51 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.